SCHEMBL18856115

SCHEMBL18856115

C=C(C)c1ccc(Cc2ccc(Cl)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.48
▸ RAB9A P51151 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ LMNA P02545 1/20 0.42
▸ MAOA P21397 3/20 0.42
▸ MAOB P27338 3/20 0.42
▸ CASP3 P42574 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ TAAR1 Q96RJ0 1/20 0.41
▸ CES2 O00748 1/20 0.41
▸ CES1 P23141 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ CTDSP1 Q9GZU7 1/20 0.40
▸ MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10599649 0.89 KMT2A (0.58) KMT2ALMNAALDH1A1SRD5A2
SCHEMBL190531 0.87 CES2 (0.50) KMT2ARAB9ANPC1L3MBTL1LMNA
SCHEMBL10492823 0.81 LMNA (0.64) KMT2AL3MBTL1LMNACASP3SENP7
SCHEMBL20041199 0.79 KMT2A (0.48) KMT2ALMNAALDH1A1SRD5A2
SCHEMBL1106684 0.76 IDO1 (0.58) KMT2ALMNATAAR1ALDH1A1MEN1
SCHEMBL19072622 0.76 KMT2A (0.45) KMT2ALMNAALDH1A1SRD5A2
SCHEMBL2132508 0.76 CA1 (0.50) KMT2ARAB9ANPC1L3MBTL1LMNA
SCHEMBL6704209 0.75 THRB (0.44) KMT2ATAAR1MEN1
SCHEMBL10389845 0.75 RAB9A (0.53) KMT2ARAB9ANPC1L3MBTL1TAAR1
SCHEMBL9065883 0.74 SRD5A2 (0.61) KMT2ARAB9ANPC1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2651888-B1 N-((1H-indol-3-yl)-alkyl)-4-benzyl)benzamide and N-((1H-pyrrolo[2,3-b]pyridin-3-yl)-alkyl)-4-benzyl)benzamide derivatives as alpha synuclein aggregation inhibitors for the treatment of neurodegenerative disorders UNIV LEUVEN KATH (BE) 2017-05-17 — — EP disclosed
Send feedback